Article
Toward a molecular equivalent dose: use of the medaka model in comparative risk assessment.
Comparative biochemistry and physiology. Toxicology & pharmacology : CBP - 1 Mar 2009
Hobbie Kristen R, Deangelo Anthony B, King Leon C, Winn Richard N, Law J McHugh
Abstract excerpt
Recent changes in the risk assessment landscape underscore the need to be able to compare the results of toxicity and dose-response testing between a growing list of animal models and, quite possibly, an array of in vitro screening assays. How do we compare test results for a given compound between vastly different species? For example, what dose level in the ambient water of a small fish model would be...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
